Table 2 |
||
|
Spearman correlations between the Framingham risk score and clinical variables in patients with rheumatoid arthritis |
||
| ρ |
P value |
|
|
|
||
| Age (years) |
0.76 |
<0.001 |
| Systolic blood pressure (mm Hg) |
0.60 |
<0.001 |
| Diastolic blood pressure (mm Hg) |
0.22 |
0.006 |
| Body mass index (kg/m2) |
-0.03 |
0.68 |
| Disease duration (years) |
0.29 |
<0.001 |
| Pack-years of smoking |
0.11 |
0.16 |
| Coronary calcium score (Agatston units) |
0.44 |
<0.001 |
| Total cholesterol (mg/dl) |
0.27 |
<0.001 |
| HDL cholesterol (mg/dl) |
-0.02 |
0.83 |
| LDL cholesterol (mg/dl) |
0.22 |
0.005 |
| Triglycerides (mg/dl) |
0.26 |
0.001 |
| Lp(a) lipoprotein (mg/dl) |
0.09 |
0.26 |
| Cumulative use of steroids (grams) |
0.17 |
0.03 |
| Cumulative use of hydroxychloroquine (grams) |
-0.05 |
0.53 |
| Modified Health Assessment Questionnaire (0–3) |
0.01 |
0.90 |
| Disease activity score (DAS28) |
0.15 |
0.07 |
|
|
||
|
Higher scores in the Modified Health Assessment Questionnaire indicate more difficulty in performing activities of daily living. Higher scores for the disease activity score using 28 joint counts (DAS28) indicate greater disease activity. HDL, high-density lipoprotein; LDL, low-density lipoprotein. |
||
|
Chung et al. Arthritis Research & Therapy 2006 8:R186 doi:10.1186/ar2098 |
||
